FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Front Vet Sci / Influence of Rho/ROCK inhibitor Y-27632 on proliferation of ...
Frontiers in veterinary science2023; 10; 1154987; doi: 10.3389/fvets.2023.1154987

Influence of Rho/ROCK inhibitor Y-27632 on proliferation of equine mesenchymal stromal cells.

Abstract: Mesenchymal stromal cells (MSC) isolated form bone marrow and adipose tissue are the most common cells used for cell therapy of orthopedic diseases. MSC derived from different tissues show differences in terms of their proliferation, differentiation potential and viability in prolonged cell culture. This suggests that there may be subtle differences in intracellular signaling pathways that modulate these cellular characteristics. The Rho/ROCK signaling pathway is essential for many cellular functions. Targeting of this pathway by the ROCK inhibitor Y-27632 has been shown to be beneficial for cell viability and proliferation of different cell types. The aim of this study was to investigate the effects of Rho/ROCK inhibition on equine MSC proliferation using bone marrow-derived MSC (BMSC) and adipose-derived MSC (ASC). Primary ASC and BMSC were stimulated with or without 10 ng/mL TGF-β3 or 10 μM Y-27632, as well as both in combination. Etoposide at 10 μM was used as a positive control for inhibition of cell proliferation. After 48 h of stimulation, cell morphology, proliferation activity and gene expression of cell senescence markers p53 and p21 were assessed. ASC showed a trend for higher basal proliferation than BMSC, which was sustained following stimulation with TGF-β3. This included a higher proliferation with TGF-β3 stimulation compared to Y-27632 stimulation ( < 0.01), but not significantly different to the no treatment control when used in combination. Expression of p21 and p53 was not altered by stimulation with TGF-β3 and/or Y-27632 in either cell type. In summary, the Rho/ROCK inhibitor Y-27632 had no effect on proliferation activity and did not induce cell senescence in equine ASC and BMSC.
Copyright © 2023 Melzer, Burk, Guest and Dudhia.
Get Full Text
Publication Date: 2023-06-06 PubMed ID: 37346276PubMed Central: PMC10279950DOI: 10.3389/fvets.2023.1154987Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study investigates the effect of Rho/ROCK inhibitor Y-27632 on the proliferation of mesenchymal stromal cells (MSC) derived from horses, specifically from their bone marrow and adipose tissue. The research discovered that the inhibitor had no significant effect on cell proliferation and did not induce cell senescence.

Objective of the Research

  • The core objective of this study was to understand the effects of Rho/ROCK inhibitor (Y-27632) on the proliferation of equine Mesenchymal Stromal Cells (MSCs) derived from bone marrow (BMSC) and adipose tissue (ASC).

Methodology

  • Both ASC and BMSC cells were stimulated with or without 10ng/mL TGF-β3 or 10μM Y-27632, individually and in combination.
  • 10μM etoposide was used as a positive control to influence the inhibition of cell proliferation.
  • Morphology of cells, their proliferation activity and gene expression of cell senescence markers p53 and p21 were assessed after 48 hours of stimulation.

Key Findings

  • ASC cells showed a slight trend for higher basal proliferation than BMSC cells, which was maintained even after stimulation with TGF-β3.
  • The research found higher proliferation in ASC cells with TGF-β3 compared to Y-27632. However, the difference was not significant when compared to the no treatment control when both TGF-β3 and Y-27632 were used in combination.
  • The expression of cell senescence markers p21 and p53 was not altered by stimulation with TGF-β3 and/or Y-27632 in either cell type signifying no induction of senescence.

Conclusion

  • In conclusion, it was found that the Rho/ROCK inhibitor, Y-27632 had no impact on cell proliferation and did not induce senescence in equine ASC and BMSC. This finding is crucial as it suggests that Y-27632 does not affect the viability or function of these cells, which are often used for therapeutic purposes.

Cite This Article

APA
Melzer M, Burk J, Guest DJ, Dudhia J. (2023). Influence of Rho/ROCK inhibitor Y-27632 on proliferation of equine mesenchymal stromal cells. Front Vet Sci, 10, 1154987. https://doi.org/10.3389/fvets.2023.1154987

Publication

Frontiers in veterinary science
ISSN: 2297-1769
NlmUniqueID: 101666658
Country: Switzerland
Language: English
Volume: 10
Pages: 1154987
PII: 1154987

Researcher Affiliations

Melzer, Michaela
  • Equine Clinic (Surgery, Orthopedics), Faculty of Veterinary Medicine, Justus Liebig University, Giessen, Germany.
Burk, Janina
  • Equine Clinic (Surgery, Orthopedics), Faculty of Veterinary Medicine, Justus Liebig University, Giessen, Germany.
Guest, Deborah J
  • Department of Clinical Sciences and Services, Royal Veterinary College, Hertfordshire, United Kingdom.
Dudhia, Jayesh
  • Department of Clinical Sciences and Services, Royal Veterinary College, Hertfordshire, United Kingdom.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

This article includes 40 references
  1. Prządka P, Buczak K, Frejlich E, Gąsior L, Suliga K, Kiełbowicz Z. The Role of Mesenchymal Stem Cells (MSCs) in Veterinary Medicine and Their Use in Musculoskeletal Disorders.. Biomolecules 2021 Aug 2;11(8).
    doi: 10.3390/biom11081141pmc: PMC8391453pubmed: 34439807google scholar: lookup
  2. Arnhold SJ, Goletz I, Klein H, Stumpf G, Beluche LA, Rohde C, Addicks K, Litzke LF. Isolation and characterization of bone marrow-derived equine mesenchymal stem cells.. Am J Vet Res 2007 Oct;68(10):1095-105.
    doi: 10.2460/ajvr.68.10.1095pubmed: 17916017google scholar: lookup
  3. Koch TG, Heerkens T, Thomsen PD, Betts DH. Isolation of mesenchymal stem cells from equine umbilical cord blood.. BMC Biotechnol 2007 May 30;7:26.
    doi: 10.1186/1472-6750-7-26pmc: PMC1904213pubmed: 17537254google scholar: lookup
  4. de Mattos Carvalho A, Alves AL, Golim MA, Moroz A, Hussni CA, de Oliveira PG, Deffune E. Isolation and immunophenotypic characterization of mesenchymal stem cells derived from equine species adipose tissue.. Vet Immunol Immunopathol 2009 Dec 15;132(2-4):303-6.
    doi: 10.1016/j.vetimm.2009.06.014pubmed: 19647331google scholar: lookup
  5. Ribitsch I, Burk J, Delling U, Geißler C, Gittel C, Jülke H, Brehm W. Basic science and clinical application of stem cells in veterinary medicine.. Adv Biochem Eng Biotechnol 2010;123:219-63.
    doi: 10.1007/10_2010_66pubmed: 20309674google scholar: lookup
  6. Spaas JH, De Schauwer C, Cornillie P, Meyer E, Van Soom A, Van de Walle GR. Culture and characterisation of equine peripheral blood mesenchymal stromal cells.. Vet J 2013 Jan;195(1):107-13.
    doi: 10.1016/j.tvjl.2012.05.006pubmed: 22717781google scholar: lookup
  7. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells.. Science 1999 Apr 2;284(5411):143-7.
    doi: 10.1126/science.284.5411.143pubmed: 10102814google scholar: lookup
  8. Kargozar S, Mozafari M, Hashemian SJ, Brouki Milan P, Hamzehlou S, Soleimani M, Joghataei MT, Gholipourmalekabadi M, Korourian A, Mousavizadeh K, Seifalian AM. Osteogenic potential of stem cells-seeded bioactive nanocomposite scaffolds: A comparative study between human mesenchymal stem cells derived from bone, umbilical cord Wharton's jelly, and adipose tissue.. J Biomed Mater Res B Appl Biomater 2018 Jan;106(1):61-72.
    doi: 10.1002/jbm.b.33814pubmed: 27862947google scholar: lookup
  9. Mohamed-Ahmed S, Fristad I, Lie SA, Suliman S, Mustafa K, Vindenes H, Idris SB. Adipose-derived and bone marrow mesenchymal stem cells: a donor-matched comparison.. Stem Cell Res Ther 2018 Jun 19;9(1):168.
    doi: 10.1186/s13287-018-0914-1pmc: PMC6008936pubmed: 29921311google scholar: lookup
  10. Wu W, Le AV, Mendez JJ, Chang J, Niklason LE, Steinbacher DM. Osteogenic performance of donor-matched human adipose and bone marrow mesenchymal cells under dynamic culture.. Tissue Eng Part A 2015 May;21(9-10):1621-32.
    doi: 10.1089/ten.TEA.2014.0115pmc: PMC4426327pubmed: 25668104google scholar: lookup
  11. Riento K, Ridley AJ. Rocks: multifunctional kinases in cell behaviour.. Nat Rev Mol Cell Biol 2003 Jun;4(6):446-56.
    doi: 10.1038/nrm1128pubmed: 12778124google scholar: lookup
  12. Kang PH, Schaffer DV, Kumar S. Angiomotin links ROCK and YAP signaling in mechanosensitive differentiation of neural stem cells.. Mol Biol Cell 2020 Mar 1;31(5):386-396.
    doi: 10.1091/mbc.E19-11-0602pmc: PMC7183791pubmed: 31940260google scholar: lookup
  13. Li W, Zhao J, Wang J, Sun L, Xu H, Sun W, Pan Y, Wang H, Zhang WB. ROCK-TAZ signaling axis regulates mechanical tension-induced osteogenic differentiation of rat cranial sagittal suture mesenchymal stem cells.. J Cell Physiol 2020 Sep;235(9):5972-5984.
    doi: 10.1002/jcp.29522pubmed: 31970784google scholar: lookup
  14. Maharam E, Yaport M, Villanueva NL, Akinyibi T, Laudier D, He Z, Leong DJ, Sun HB. Rho/Rock signal transduction pathway is required for MSC tenogenic differentiation.. Bone Res 2015;3:15015.
    doi: 10.1038/boneres.2015.15pmc: PMC4605238pubmed: 26509098google scholar: lookup
  15. Kamishibahara Y, Kawaguchi H, Shimizu N. Rho kinase inhibitor Y-27632 promotes neuronal differentiation in mouse embryonic stem cells via phosphatidylinositol 3-kinase.. Neurosci Lett 2016 Feb 26;615:44-9.
    doi: 10.1016/j.neulet.2016.01.022pubmed: 26797580google scholar: lookup
  16. Li Z, Han S, Wang X, Han F, Zhu X, Zheng Z, Wang H, Zhou Q, Wang Y, Su L, Shi J, Tang C, Hu D. Rho kinase inhibitor Y-27632 promotes the differentiation of human bone marrow mesenchymal stem cells into keratinocyte-like cells in xeno-free conditioned medium.. Stem Cell Res Ther 2015 Mar 11;6(1):17.
    doi: 10.1186/s13287-015-0008-2pmc: PMC4393638pubmed: 25889377google scholar: lookup
  17. Melzer M, Schubert S, Müller SF, Geyer J, Hagen A, Niebert S, Burk J. Rho/ROCK Inhibition Promotes TGF-β3-Induced Tenogenic Differentiation in Mesenchymal Stromal Cells.. Stem Cells Int 2021;2021:8284690.
    doi: 10.1155/2021/8284690pmc: PMC8519677pubmed: 34659420google scholar: lookup
  18. Kümper S, Mardakheh FK, McCarthy A, Yeo M, Stamp GW, Paul A, Worboys J, Sadok A, Jørgensen C, Guichard S, Marshall CJ. Rho-associated kinase (ROCK) function is essential for cell cycle progression, senescence and tumorigenesis.. Elife 2016 Jan 14;5:e12994.
    doi: 10.7554/eLife.12203pmc: PMC4798951pubmed: 26765561google scholar: lookup
  19. Chapman S, McDermott DH, Shen K, Jang MK, McBride AA. The effect of Rho kinase inhibition on long-term keratinocyte proliferation is rapid and conditional.. Stem Cell Res Ther 2014 Apr 28;5(2):60.
    doi: 10.1186/scrt449pmc: PMC4055106pubmed: 24774536google scholar: lookup
  20. Joo HJ, Choi DK, Lim JS, Park JS, Lee SH, Song S, Shin JH, Lim DS, Kim I, Hwang KC, Koh GY. ROCK suppression promotes differentiation and expansion of endothelial cells from embryonic stem cell-derived Flk1(+) mesodermal precursor cells.. Blood 2012 Sep 27;120(13):2733-44.
    doi: 10.1182/blood-2012-04-421610pubmed: 22896004google scholar: lookup
  21. Jung B, Lee H, Kim S, Tchah H, Hwang C. Effect of Rho-Associated Kinase Inhibitor and Mesenchymal Stem Cell-Derived Conditioned Medium on Corneal Endothelial Cell Senescence and Proliferation.. Cells 2021 Jun 11;10(6).
    doi: 10.3390/cells10061463pmc: PMC8230597pubmed: 34207965google scholar: lookup
  22. Claassen DA, Desler MM, Rizzino A. ROCK inhibition enhances the recovery and growth of cryopreserved human embryonic stem cells and human induced pluripotent stem cells.. Mol Reprod Dev 2009 Aug;76(8):722-32.
    doi: 10.1002/mrd.21021pmc: PMC3257892pubmed: 19235204google scholar: lookup
  23. Martin-Ibañez R, Unger C, Strömberg A, Baker D, Canals JM, Hovatta O. Novel cryopreservation method for dissociated human embryonic stem cells in the presence of a ROCK inhibitor.. Hum Reprod 2008 Dec;23(12):2744-54.
    doi: 10.1093/humrep/den316pubmed: 18716037google scholar: lookup
  24. Godwin EE, Young NJ, Dudhia J, Beamish IC, Smith RK. Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon.. Equine Vet J 2012 Jan;44(1):25-32.
    doi: 10.1111/j.2042-3306.2011.00363.xpubmed: 21615465google scholar: lookup
  25. Guest DJ, Dudhia J, Smith RKW, Roberts SJ, Conzemius M, Innes JF, Fortier LA, Meeson RL. Position Statement: Minimal Criteria for Reporting Veterinary and Animal Medicine Research for Mesenchymal Stromal/Stem Cells in Orthopedic Applications.. Front Vet Sci 2022;9:817041.
    doi: 10.3389/fvets.2022.817041pmc: PMC8936138pubmed: 35321059google scholar: lookup
  26. Guest DJ, Ousey JC, Smith MR. Defining the expression of marker genes in equine mesenchymal stromal cells.. Stem Cells Cloning 2008;1:1-9.
    doi: 10.2147/sccaa.s3824pmc: PMC3781685pubmed: 24198500google scholar: lookup
  27. Yang H, Wang H, Ren J, Chen Q, Chen ZJ. cGAS is essential for cellular senescence.. Proc Natl Acad Sci U S A 2017 Jun 6;114(23):E4612-E4620.
    doi: 10.1073/pnas.1705499114pmc: PMC5468617pubmed: 28533362google scholar: lookup
  28. Lamas NJ, Serra SC, Salgado AJ, Sousa N. Failure of Y-27632 to improve the culture of adult human adipose-derived stem cells.. Stem Cells Cloning 2015;8:15-26.
    doi: 10.2147/SCCAA.S66597pmc: PMC4293935pubmed: 25609984google scholar: lookup
  29. Hernandez-Segura A, Nehme J, Demaria M. Hallmarks of Cellular Senescence.. Trends Cell Biol 2018 Jun;28(6):436-453.
    doi: 10.1016/j.tcb.2018.02.001pubmed: 29477613google scholar: lookup
  30. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR.. Nucleic Acids Res 2001 May 1;29(9):e45.
    doi: 10.1093/nar/29.9.e45pmc: PMC55695pubmed: 11328886google scholar: lookup
  31. Li X, Bai J, Ji X, Li R, Xuan Y, Wang Y. Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation.. Int J Mol Med 2014 Sep;34(3):695-704.
    doi: 10.3892/ijmm.2014.1821pmc: PMC4121354pubmed: 24970492google scholar: lookup
  32. De Ugarte DA, Morizono K, Elbarbary A, Alfonso Z, Zuk PA, Zhu M, Dragoo JL, Ashjian P, Thomas B, Benhaim P, Chen I, Fraser J, Hedrick MH. Comparison of multi-lineage cells from human adipose tissue and bone marrow.. Cells Tissues Organs 2003;174(3):101-9.
    doi: 10.1159/000071150pubmed: 12835573google scholar: lookup
  33. Ishizaki T, Uehata M, Tamechika I, Keel J, Nonomura K, Maekawa M, Narumiya S. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases.. Mol Pharmacol 2000 May;57(5):976-83.
    pubmed: 10779382
  34. Xu B, Song G, Ju Y, Li X, Song Y, Watanabe S. RhoA/ROCK, cytoskeletal dynamics, and focal adhesion kinase are required for mechanical stretch-induced tenogenic differentiation of human mesenchymal stem cells.. J Cell Physiol 2012 Jun;227(6):2722-9.
    doi: 10.1002/jcp.23016pubmed: 21898412google scholar: lookup
  35. Rao PV, Deng PF, Kumar J, Epstein DL. Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632.. Invest Ophthalmol Vis Sci 2001 Apr;42(5):1029-37.
    pubmed: 11274082
  36. Ji H, Tang H, Lin H, Mao J, Gao L, Liu J, Wu T. Rho/Rock cross-talks with transforming growth factor-β/Smad pathway participates in lung fibroblast-myofibroblast differentiation.. Biomed Rep 2014 Nov;2(6):787-792.
    doi: 10.3892/br.2014.323pmc: PMC4179758pubmed: 25279146google scholar: lookup
  37. Kim K, Gil M, Dayem AA, Choi S, Kang GH, Yang GM, Cho S, Jeong Y, Kim SJ, Seok J, Kwak HJ, Saha SK, Kim A, Cho SG. Improved Isolation and Culture of Urine-Derived Stem Cells (USCs) and Enhanced Production of Immune Cells from the USC-Derived Induced Pluripotent Stem Cells.. J Clin Med 2020 Mar 18;9(3).
    doi: 10.3390/jcm9030827pmc: PMC7141314pubmed: 32197458google scholar: lookup
  38. Wang T, Kang W, Du L, Ge S. Rho-kinase inhibitor Y-27632 facilitates the proliferation, migration and pluripotency of human periodontal ligament stem cells.. J Cell Mol Med 2017 Nov;21(11):3100-3112.
    doi: 10.1111/jcmm.13222pmc: PMC5661246pubmed: 28661039google scholar: lookup
  39. Bueno C, Montes R, Menendez P. The ROCK inhibitor Y-27632 negatively affects the expansion/survival of both fresh and cryopreserved cord blood-derived CD34+ hematopoietic progenitor cells: Y-27632 negatively affects the expansion/survival of CD34+HSPCs.. Stem Cell Rev Rep 2010 Jun;6(2):215-23.
    doi: 10.1007/s12015-010-9118-5pubmed: 20180051google scholar: lookup
  40. Li X, Zhou Q, Wang S, Wang P, Li J, Xie Z, Liu C, Wen J, Wu X. Prolonged treatment with Y-27632 promotes the senescence of primary human dermal fibroblasts by increasing the expression of IGFBP-5 and transforming them into a CAF-like phenotype.. Aging (Albany NY) 2020 Aug 25;12(16):16621-16646.
    doi: 10.18632/aging.103910pmc: PMC7485707pubmed: 32843583google scholar: lookup

Citations

This article has been cited 1 times.
  1. Shi J, Cai J, Kong L, Ying L, Liu X, Jiang M, Pan D. Upregulation of miR-183 inhibits the invasion and migration of endometrial stromal cells in endometriosis patients by downregulating Ezrin. Front Oncol 2025;15:1537528.
    doi: 10.3389/fonc.2025.1537528pubmed: 40630207google scholar: lookup
Subscribe to our newsletter
Join 99,359 horse owners like you who receive our email updates on horse health and nutrition.